+20.1%
GSK vs DD
+34.9%
-14.7%
-19.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | DD | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | -0.3% | +0.3% | +0.1% |
| 7D | -3.5% | -3.5% | 0.0% | -3.0% |
| 30D | -3.4% | -11.7% | +8.2% | -1.7% |
| 3M | -8.1% | -9.2% | +1.1% | -7.0% |
| 6M | -11.1% | -7.2% | -3.9% | -11.0% |
| YTD | +0.7% | +6.6% | -5.9% | -1.3% |
| 1Y | +20.1% | +32.0% | -11.9% | +14.9% |
| All | +20.1% | +34.9% | -14.7% | +14.9% |
Cumulative growth
Daily Returns
Daily percentage return beside DD.
Daily Out/Under-Performance
Portfolio return minus DD return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × DD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded DD wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling